Mural Oncology PLC Logo

Mural Oncology PLC

Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.

MURA | BUD

Overview

Corporate Details

ISIN(s):
IE000LK2BOB4
LEI:
Country:
Ireland
Address:
N/A
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Mural Oncology PLC is a clinical-stage oncology company focused on developing novel immunotherapies to treat cancer. The company leverages its proprietary protein engineering platform and expertise in cytokine biology to design and advance a pipeline of cytokine-based therapies. Its mission is to unlock the value of immunotherapy for a broader range of patients, particularly those with cancers that have not responded to previous treatments. The company's lead candidate, nemvaleukin alfa, is a novel, engineered interleukin-2 (IL-2) variant immunotherapy currently in clinical trials for difficult-to-treat solid tumors, including advanced melanoma and platinum-resistant ovarian cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-24 22:25
Post-Annual General Meeting Information
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisiti…
English 31.3 KB
2025-09-24 01:52
Proxy Solicitation & Information Statement
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement …
English 18.3 KB

Automate Your Workflow. Get a real-time feed of all Mural Oncology PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mural Oncology PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mural Oncology PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bonus BioGroup Ltd. Logo
Develops cell therapies and tissue products for bone grafts and inflammation repair.
Israel
BONS
BRAIN Biotech AG Logo
Develops custom enzymes and microbes for the food, nutrition, and chemical industries.
Germany
BNN
Branding Technology Inc. Logo
Drives digital transformation for SMEs with data-driven digital marketing and brand development.
Japan
7067
BriaCell Therapeutics Corp. Logo
Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.
United States of America
BCTX
BrightBid Group Logo
AI SaaS platform automating paid search & shopping ads for businesses to maximize ROI.
Sweden
BRIGHT
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan
4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden
BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan
302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden
BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea
230980

Talk to a Data Expert

Have a question? We'll get back to you promptly.